https://www.selleckchem.com/pr....oducts/mk-8353-sch90
Remdesivir is being studied and used for treatment of coronavirus disease 2019 (COVID-19). To update a previous review of remdesivir for adults with COVID-19, including new meta-analyses of patients with COVID-19 of any severity compared with control. Several sources from 1 January 2020 through 7 December 2020. English-language, randomized controlled trials (RCTs) of remdesivir for COVID-19. New evidence is incorporated by using living review methods. 1 reviewer abstracted data; a second reviewer verified the data. The Cochran
Aimer
Commentaire
Partagez
